CCL2 and prostate cancer: For instance, polycomb repressive complex 1 (PRC1) promotes metastasis of double negative [androgen receptor (AR) and neuroendocrine] prostate cancers by CCL2 expression, which regulates TAM self-renewal and recruitment [20].